Identity & Authority: Novo Nordisk – Signal Evidence & AI Readability

Novo Nordisk

(https://novonordisk.com) 📸 Data Snapshot: May 30, 2026
Identity & Authority — The Lens

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Identity & Authority Expert verifiability & Schema depth.
6 Impact Weight: 15 / 100
40% Reputation

A significant technical authority gap exists due to the total absence of JSON-LD schema across all crawled pages and missing H1 tags on the homepage and medicines pages. While the brand carries global recognition, the digital footprint lacks structured data to verify organizational entities or expert personnel. This technical negligence contrasts with the company’s claim of being a leading global healthcare company.

There is almost no disconnect between marketing claims and demonstrated evidence. The site claims to be science-driven and demonstrates this through the inclusion of the R&D Pipeline link and the Annual Report 2025. Unlike lower-tier sites, Novo Nordisk provides specific percentages (20.7% weight loss) rather than vague promises of transformation.

Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.

🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage — no schema detected (entity gap)
/news-and-media/news-and-ir-materials/news-details.html — no schema detected (entity gap)
/our-products/our-medicines.html — no schema detected (entity gap)
/news-and-media/news-and-ir-materials.html — no schema detected (entity gap)
🛡️ Trust Signals — external proof links that back the declared identity
0Review mentions (all pages)
4External proof links (all pages)
PageReviewsProof links
/ (home) 0 1
/news-and-media/news-and-ir-materials/news-details.html 0 1
/our-products/our-medicines.html 0 1
/news-and-media/news-and-ir-materials.html 0 1